These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 12597334)
21. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast. Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158 [TBL] [Abstract][Full Text] [Related]
22. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394 [TBL] [Abstract][Full Text] [Related]
23. Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. Morphopoulos G; Pearson M; Ryder WD; Howell A; Harris M J Pathol; 1996 Sep; 180(1):44-9. PubMed ID: 8943814 [TBL] [Abstract][Full Text] [Related]
24. [Immunohistochemical study of angiogenesis of axillary lymph node metastasis in human breast carcinoma]. Wu L; Zhang W; Liu H Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):433-5. PubMed ID: 11776619 [TBL] [Abstract][Full Text] [Related]
25. Comparison of Microvessel Density with Prognostic Factors in Invasive Ductal Carcinomas of the Breast. Şener E; Şipal S; Gündoğdu C Turk Patoloji Derg; 2016; 32(3):164-70. PubMed ID: 27562390 [TBL] [Abstract][Full Text] [Related]
26. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR; Abd-Elwahed SR; Abdulwahed AR Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077 [TBL] [Abstract][Full Text] [Related]
27. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence. Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807 [TBL] [Abstract][Full Text] [Related]
28. Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: Comparative study with invasive ductal carcinoma-not otherwise specified. Li W; Yang D; Wang S; Guo X; Lang R; Fan Y; Gu F; Zhang X; Niu Y; Yan X; Fu L Pathol Res Pract; 2011 Dec; 207(12):739-46. PubMed ID: 22051146 [TBL] [Abstract][Full Text] [Related]
29. Correlation between tumor angiogenesis and metastasis in breast cancer. Chu JS; Lee WJ; Chang TC; Chang KJ; Hsu HC J Formos Med Assoc; 1995 Jul; 94(7):373-8. PubMed ID: 7549559 [TBL] [Abstract][Full Text] [Related]
30. Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast. Sapino A; Bongiovanni M; Cassoni P; Righi L; Arisio R; Deaglio S; Malavasi F J Pathol; 2001 Jun; 194(2):254-61. PubMed ID: 11400156 [TBL] [Abstract][Full Text] [Related]
31. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis. D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704 [TBL] [Abstract][Full Text] [Related]
32. Angiogenesis in breast cancer is related to age but not to other prognostic parameters. Marinho A; Soares R; Ferro J; Lacerda M; Schmitt FC Pathol Res Pract; 1997; 193(4):267-73. PubMed ID: 9258952 [TBL] [Abstract][Full Text] [Related]
33. [Some morphometric parameters of nucleoli and nuclei in invasive ductal breast carcinomas in women]. Karpinska-Kaczmarczyk K Ann Acad Med Stetin; 2009; 55(1):90-6. PubMed ID: 20349598 [TBL] [Abstract][Full Text] [Related]
34. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast. Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796 [TBL] [Abstract][Full Text] [Related]
35. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259 [TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor expression in the basal subtype of breast carcinoma. Ribeiro-Silva A; Ribeiro do Vale F; Zucoloto S Am J Clin Pathol; 2006 Apr; 125(4):512-8. PubMed ID: 16627261 [TBL] [Abstract][Full Text] [Related]
37. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry]. Masiuk M Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394 [TBL] [Abstract][Full Text] [Related]
38. Angiogenesis and mast cells in human breast cancer sentinel lymph nodes with and without micrometastases. Ribatti D; Finato N; Crivellato E; Guidolin D; Longo V; Mangieri D; Nico B; Vacca A; Beltrami CA Histopathology; 2007 Dec; 51(6):837-42. PubMed ID: 17944928 [TBL] [Abstract][Full Text] [Related]
39. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis. Schoell WM; Pieber D; Reich O; Lahousen M; Janicek M; Guecer F; Winter R Cancer; 1997 Dec; 80(12):2257-62. PubMed ID: 9404702 [TBL] [Abstract][Full Text] [Related]
40. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. Su MY; Cheung YC; Fruehauf JP; Yu H; Nalcioglu O; Mechetner E; Kyshtoobayeva A; Chen SC; Hsueh S; McLaren CE; Wan YL J Magn Reson Imaging; 2003 Oct; 18(4):467-77. PubMed ID: 14508784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]